Announcements Trials
Browse Landscape

Phase

Phase 4 1Phase 3 1Phase 2 1Phase 1 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1

Conditions

Polycystic Ovary Syndrome 41Obesity 9Anovulation 8Infertility 7Insulin Resistance 6Overweight 2Non-alcoholic Fatty Liver Disease 2Hirsutism 2Diabetes, Gestational 2Breast Neoplasms 2Urinary Bladder Neoplasms 1Thyroid Nodule 1Racism 1Prostatic Neoplasms 1Pregnancy Complications 1Mouth Neoplasms 1Metabolic Syndrome 1Hyperandrogenism 1Endometrial Neoplasms 1Endometrial Hyperplasia 1Dyslipidemias 1Diabetes Mellitus, Type 2 1Breast Cancer Female 1Body Weight 1Amenorrhea 1Acne Vulgaris 1

Interventions

dopexamine 1Tobacco Use Cessation Devices 1Starch 1Radiotherapy 1Psychiatric Rehabilitation 1Propofol 1Polymerase Chain Reaction 1Norepinephrine 1Midazolam 1Metformin 1Magnetic Resonance Spectroscopy 1Gene Expression Profiling 1Epinephrine 1Early Intervention, Educational 1Dobutamine 1Counseling 1Contrast Media 1Bupropion 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 4 × Mouth Neoplasms × Metformin × Clear all
NCT03684707 2018-09-26

Cancer Chemoprevention by Metformin Hydrochloride Compared to Placebo in Oral Potentially Malignant Lesions

Ain Shams University

Phase 4 Unknown
30 enrolled
Head & Neck

Mouth Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡